Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy

Retina

Volumn 31, Issue 9, 2011, Pages 1912-1920

  Shinojima, Ari ^a   Kawamura, Akiyuki ^a   Mori, Ryusaburo ^a   Fujita, Kyoko ^a   Yuzawa, Mitsuko ^a  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

Author keywords

central serous chorioretinopathy; inner and outer segment junction line; pigment epithelial detachment; retinal pigment epithelium (RPE); RPE irregularity; RPE layer form; serous retinal detachment; spectraldomain optical coherence tomography

Indexed keywords

VERTEPORFIN;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; CHRONIC CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MALE; PHOTODYNAMIC THERAPY; PHOTORECEPTOR INNER SEGMENT; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; RETINA DETACHMENT; RETINA FOVEA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME;

ADULT; CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RECURRENCE; RETINAL DETACHMENT; RETINAL PHOTORECEPTOR CELL INNER SEGMENT; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 80053370809     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182252aa8     Document Type: Article

References (18)

1. Chan WM, Lam DSC, Chan CKM, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-1458.
2. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic central serous chorioretinopathy. Retina 2003;23:235-237.
3. Yannuzzi LA. Central serous chorioretinopathy: A personal perspective. Am J Ophthalmol 2010;149:361-363.
4. Schlötzer-Schrehardt U, Viestenz A, Naumann GO, et al. Doserelated structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 2002;240:748-757.
5. Chan WM, Lai TY, Lai RY, et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy one-year results of a randomized controlled trial. Ophthalmology 2008;115:1756-1765.
6. Chan WM, Lai TY, Lai RY, et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: One-year results of a prospective study. Retina 2008;28:85-93.
7. Reibaldi M, Cardascia N, Longo A, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: A nonrandomized clinical trial. Am J Ophthalmol 2010;149:307-315.
8. Shinojima A, Hirose T, Mori R, et al. Morphologic findings in acute CSC using spectral domain OCT with simultaneous angiography. Retina 2010;30:193-202.
9. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057-1062.
10. Piccolino FC, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye (Lond) 1995;9:324-332.
11. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16:203-212.
12. Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010;149:441-446.
13. Moon JW, Yu HG, Kim TW, et al. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009;247:1315-1323.
14. Matsumoto H, Sato T, Kishi S. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 2009;148:105-110.
15. Schocket LS, Witkin AJ, Fujimoto JG, et al. Ultra-high resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. Ophthalmology 2006;113:666-672.
16. Green WR. The uveal tract. In: Spencer WH, ed. Ophthalmic Pathology. Vol 3. 4th ed. Philadelphia, PA: Saunders; 1996: 1455-1461.
17. Iwaki Y. Mechanism of the development of experimental central serous chorioretinopathy in the rabbit [in Japanese]. Kurume Igakukai Zassi 1992;55:352-362.
18. Krishan NR, Chandra SR, Stevens TS. Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol 1985;100:698-707.